Senior insider sale
Chief Executive Officer at UNITY BIOTECHNOLOGY, INC. — senior position signals high conviction
$100.7K
97.44K shares
What this filing means
GHOSH ANIRVAN plans to sell 97.44K shares of UNITY BIOTECHNOLOGY, INC. valued at approximately $100.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/3/2025ACC: 0000950170-25-050401
DirectorOfficer· Chief Executive Officer
Since Mar 2020
97.44K
Shares to sell
$100.7K
Approx. market value
96.80K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units granted in 2025 under the Issuer's 2018 Incentive Award Plan
N/A
3/28/2025
96.80KTotal acquired96.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/28/2025 | Restricted Stock Units granted in 2025 under the Issuer's 2018 Incentive Award Plan N/A | 96.80K | — |
| Total | 96.80K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
642.00
Market value
$1.4K
2/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
96.80K
Market value
$99.3K
4/2/2025
Total
Units
97.44K
Value
$100.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2025 | 642.00 | $1.4K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2025 | 96.80K | $99.3K | NASDAQ | Planned |
| Total | 97.44K | $100.7K | ||